Skip to main content
. 2016 Aug 23;7(39):63437–63448. doi: 10.18632/oncotarget.11521

Figure 3. PCA (A), OPLS-DA (B), and permutation tests (C) of RRLC-based targeted metabolic profiling. (Healthy controls, ◆; Lung cancer patients, ◇).

Figure 3